Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 Slide Shows
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
CES 2010 Coverage 

Follow Us
RTTNews on Twitter RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube


Font Down Font Up
Qiagen Q3 Profit Soars, Beats View; Tightens FY09 Earnings View - Update
11/9/2009 6:47 PM ET

RELATED NEWS
QIAGEN NV Q4 09 Earnings Conference Call At 9:30 AM ET
QIAGEN Q4 Profit Increases; Provides FY10 Guidance - Quick Facts
QIAGEN To Present At The JPMorgan 28th Annual Healthcare Conference; Webcast At 2:30 PM ET
WuXi AppTec And QIAGEN Enter Into Partnership Deal For Molecular Biomarker Development - Quick Facts
Qiagen Closes Acquisition Of SABiosciences - Quick Facts

Trade QGEN now with
(RTTNews) - Monday, sample and assay technologies provider Qiagen NV (QGEN: News ) reported a 81% rise in profit for the third quarter, on a 13% growth in sales and strong operating margins. Earnings for the quarter, as well as revenues came in above analysts' expectations. The company narrowed its full year adjusted earnings view towards higher end of its prior estimate.

The Venlo, the Netherlands-based company's net income attributable to its shareholders surged 81% to US$37.69 million from US$20.79 million in the same quarter last year. Earnings per share for the third quarter increased 80% to US$0.18 in 2009 from US$0.10 in the year earlier period.

Excluding total adjustments of $15.82 million or $0.08 per share for the recent quarter, adjusted net income increased 26% to US$53.51 million from US$42.36 million for the year earlier period. Adjusted earnings per share rose 24% to US$0.26 from US$0.21 a year-ago.

Analysts polled by Thomson Reuters expected the company to report earnings of US$0.23 per share for the quarter. Analysts' estimates typically exclude special items.

The adjustments for the recent quarter include, purchased intangibles amortization expense of US$11.42 million or US$0.06 per share and costs related to acquisition of DxS Ltd. of US$4.12 million or US$0.02 per share.
Quarterly net sales for the quarter was US$259.66 million, up 13% from US$230.80 million in the same quarter a year-ago. Excluding the unfavorable impact from foreign currency exchange rates, net sales for the third quarter 2009 would have increased 16%. Analyst estimated revenues of US$256.88 million for the quarter.

In the sequentially preceding second quarter, the company's net income attributable to the company increased to US$30.93 million or US$0.15 per share from US$23.22 million or US$0.11 per share in the previous year second quarter. On an adjusted basis, second quarter net income was US$48.26 million or US$0.24 per share, compared to US$40.40 million or US$0.20 per share in the prior year second quarter. Net sales for the second quarter had increased to US$240.16 million from US$217.89 million for the same quarter last year.

Commenting on the third quarter performance, Peer Schatz, QIAGEN's Chief Executive Officer said, "We saw strong growth in revenues, operating margins and adjusted net income -- all of which exceeded our guidance. In addition, our organic revenue growth came in very strong at 15%."

"Revenue growth was highest in sales to customers in molecular diagnostics (approximately 50% of total revenues) followed by sales to customers in pharma (approximately 21% of total revenues), in applied testing (approximately 6% of total revenues) and in academia (approximately 23% of total revenues)," Schatz added.

To receive FREE breaking news email alerts for QIAGEN NV and others in your portfolio


 1   2   Next Page 


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print           Follow Us RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

     
Top Stories
Obama Meets With House And Senate Leaders In Effort To Boost Bipartisanship

Opel/Vauxhall Unveils €11 Bln Investment Plan; To Cut 8,300 Jobs

S&P Trims Outlook On BofA, Citigroup; Affirms Ratings - Update

House GOP Leaders Demand White House Scrap Health Reform Legislation Prior To Summit

Molson Coors Posts Higher Profit

Earnings
BCB Bancorp FY09 Profit Rises - Quick Facts

ATA Automation Q3 Profit Declines - Update

Synex International Q2 Net Income Declines - Quick Facts

Triple-S Management Q4 Profit Up, Tops View - Update

Stepan Q4 Profit Surges - Update

US Market Commentary
TSX Jumps On Greece Rescue Rumors

Stocks Building On Strong Gains In Early Afternoon Trading - U.S. Commentary

Stocks Give Back Ground But Remain Mostly Higher - U.S. Commentary

Stocks Posting Strong Gains In Mid-Morning Trading - U.S. Commentary

Stocks Seeing Early Strength As Traders Go Bargain Hunting - U.S. Commentary

US Economic News
Bernanke Hearing Postponed Due To Weather

Wholesale Inventories Show Unexpected Decrease In December

Wholesale Inventories Fell 0.8% In December

Small Business Optimism Shows Slight Improvement In January

Cloudy Jobs Picture Accentuating Consumer Worries

Political News
New Cook Political Report Calls Murtha's Former District A "Tossup"

Obama Meets With House And Senate Leaders In Effort To Boost Bipartisanship

House GOP Leaders Demand White House Scrap Health Reform Legislation Prior To Summit

Sri Lankan President Dissolves Parliament Ahead Of Schedule

Bernanke Hearing Postponed Due To Weather




 
Obama Meets With Congressional Leaders
02/09/10 01:03
Stocks Bounce Back Early Tuesday
02/09/10 10:18
Rep. Murtha Dies; Nuclear Tensions With Iran
02/08/10 05:00
 

Today's Stocks to Watch
PSOF - Pansoft Company Limited
RBCN - RUBICON TECHNOLOGY,
NTUR.OB - Natural Blue Resources, Inc.
SNSS - Sunesis Pharmaceuticals Inc.
SITO.OB - Single Touch Systems Inc.
MKTX - MARKETAXESS HOLDINGS INC


Hopes of Diffusion of European Debt Crisis May Lead to Some Bargain Hunting
The major U.S. index futures are pointing to a higher opening on Tuesday, with European debt concerns receding following indications from European Commission officials that they may step in to save Greece from getting mired in the debt crisis. Commodity prices are extending their gains and this coupled with the oversold levels of the markets may support a bounce back. Given the fact that the wholesale inventories report to be released after the markets close is not market moving, the markets may derive support from hopes that the economic revival may not lose steam despite the surrounding uncertainty.
The Week In Washington  Lawmakers spent a busy week in Washington discussing the recently unveiled Fiscal Year 2011 budget, and the Democrats new jobs agenda

 

Copyright © 2010 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service| How To Use RTTNews.com| Advertise| Privacy| Buy Content | RSS